| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/30/2006 | CA2579820A1 Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity |
| 03/30/2006 | CA2579313A1 Pyrazole kinase modulators and methods of use as c-kit or fit-3 kinase inhibitors |
| 03/30/2006 | CA2577818A1 New heterocyclic amides |
| 03/30/2006 | CA2577772A1 Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 03/29/2006 | EP1638969A2 Cgrp receptor antagonists |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638963A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 03/29/2006 | EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 03/29/2006 | EP1638954A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 03/29/2006 | EP1638953A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 03/29/2006 | EP1638944A1 Tachykinin receptor antagonists |
| 03/29/2006 | EP1638943A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 03/29/2006 | EP1638942A1 Cis-2,4,5-triaryl-imidazolines |
| 03/29/2006 | EP1638939A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/29/2006 | EP1638938A2 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 03/29/2006 | EP1638935A1 Nk1 antagonist |
| 03/29/2006 | EP1638934A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 03/29/2006 | EP1638932A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 03/29/2006 | EP1638565A2 Substituted piperidine compounds and methods of their use |
| 03/29/2006 | EP1638540A2 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 03/29/2006 | EP1461083B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 03/29/2006 | EP1409478B1 Improved process for preparing benzimidazole-type compounds |
| 03/29/2006 | EP1379234B1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 03/29/2006 | EP1332137B1 Treatment of gastrointestinal stromal tumors |
| 03/29/2006 | EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/29/2006 | EP1227086B1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| 03/29/2006 | EP0979823B1 Novel amide compounds and drugs containing the same |
| 03/29/2006 | CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 03/29/2006 | CN1753890A Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753885A Optically active dihydropyridine derivative |
| 03/29/2006 | CN1753882A Ethynyl derivatives serving as factor XA inhibitors |
| 03/29/2006 | CN1753877A Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 03/29/2006 | CN1753876A New pyridazin-3(2h)-one derivatives |
| 03/29/2006 | CN1753872A Process for the production of substituted nicotinic acid esters |
| 03/29/2006 | CN1753871A Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 03/29/2006 | CN1753870A Novel benzamide derivatives and process for production thereof |
| 03/29/2006 | CN1753679A Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/29/2006 | CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/29/2006 | CN1753668A 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 03/29/2006 | CN1752086A Improved method of preparing azhediping |
| 03/29/2006 | CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 03/29/2006 | CN1247590C Process for synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247572C Method of producing nitroguanidine-and nitroenamine derivatives |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247569C Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts |
| 03/29/2006 | CN1247568C Novel urea compounds as vanilloid receptor antagonist for treatment of pains |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247548C Cesium triazoleamide compounds and their preparation and use |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247529C Process for preparing N-aroyl-L-glutaminic acid |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019144 E.g. 1-(4-methanesulfonylphenyl)-5-phenyl-3-trifluoromethyl-1H-1,2,4-triazole; side effect reduction; antipyretics; analgesics; non-steroidal antiinflamatory agents; cyclooxygenase 2 inhibitors; anticarcinogenic agents; Alzheimer's disease; antiulcer agents; gastrointestinal disorders |
| 03/28/2006 | US7019143 3-Carboxy,4-oxo-quinoline antibiotics; 7-substituted with-1-piperidine, 1-pyrrolidine or 1-azetidine; multistep synthesis from the 2,4-difluorobenzoic acids; acetylation, amination, cyclization; 7-((3R)-(1S-aminoethyl)-1-pyrrolidinyl)-1-cyclopropyl-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid |
| 03/28/2006 | US7019137 Alkylation of 2,3-dihydro-1,4-benzodioxin-5-amine in chlorobenzene using trifluoromethanesulfonic acid salts of N,N-bis(2-chloroethyl)-alanine methyl ester, to form serotonin receptor antagonists; nervous system disorders |
| 03/28/2006 | US7019094 Intermediate products, methods for their preparation and use thereof |
| 03/28/2006 | US7019053 Stabilizer mixtures |
| 03/28/2006 | US7019017 Small molecule inhibitors of HER2 expression |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019005 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound. |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018996 Bactericides, antiseptic; Streptomyces culture; peptide antibiotics |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018960 Formed by inter-molecular interaction of one or more keto-enol tautomeric compounds; for mechanical friction sliding members |
| 03/28/2006 | US7018611 Vitronectin receptor antagonist pharmaceuticals |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2290963C S-omeprazole magnesium trihydrate |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/28/2006 | CA2252229C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 03/28/2006 | CA2164677C Stabilized polyvinyl chloride |
| 03/28/2006 | CA2147451C 3-indolylpiperidines |
| 03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | WO2006031764A2 Processes for prepating n-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and intermediates |
| 03/23/2006 | WO2006031674A1 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates |
| 03/23/2006 | WO2006030984A1 Piperidine compound and process for preparing the same |
| 03/23/2006 | WO2006030975A1 Piperidine derivatives and use thereof |
| 03/23/2006 | WO2006030936A1 Method and apparatus for producing oxidized compound |
| 03/23/2006 | WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | WO2006029912A1 Indole derivatives as antiviral agents |
| 03/23/2006 | WO2006029906A1 Methylene dipiperidine derivatives |
| 03/23/2006 | WO2006029829A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 03/23/2006 | WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 03/23/2006 | WO2005082892A3 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them |
| 03/23/2006 | WO2005014577A9 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063932 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |